Real-time enrollment status for this figo stage iii and iv ovarian cancer clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 4:42 PM UTC
| NCT Number | NCT07322094 |
| Recruiting Status | Recruiting |
| Condition | FIGO Stage III and IV Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 7 sites in the US |
| Sponsor | TORL Biotherapeutics, LLC |
| Last Updated on CT.gov | July 13, 2026 (Yesterday) |
As of July 14, 2026: Clinical trial NCT07322094 is currently recruiting participants. This phase1 study for figo stage iii and iv ovarian cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by TORL Biotherapeutics, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07322094 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07322094 was last updated Yesterday (July 13, 2026). HelloStudys verifies this status automatically.